Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A clinical trial to investigate the influence of CYP2C19 polymorphism on
pharmacokinetic/pharmacodynamic characteristics of omeprazole in healthy Korean volunteers